News about vaccines: events, facts and developments on tafs uz.
3 stories
Alexander Gintsburg, scientific director of the Gamaleya center, said that the spread of the new coronavirus variant PJ.2.1 in the United States and Europe is grounds for monitoring the strain and checking whether existing vaccines remain relevant. According to him, modeling cannot replace experiments with the antibodies of those vaccinated with Sputnik V.
Aziz KarimovThe first clinical trial of a vaccine against the Ebola Bundibugyo strain — the cause of the largest outbreak in the country’s history, with more than 9,700 cases and over 4,600 deaths — has begun in the Democratic Republic of the Congo. The trial, named Tumaini (‘hope’ in Swahili), started with the administration of the Ervebo vaccine in Bunia, the capital of Ituri province. Two Bundibugyo-specific candidates — developed by the University of Oxford and Moderna — are expected to join the trial soon.
Javlon TursunovThe UK government has said it is ready to review the Vaccine Damage Payment Scheme (VDPS) following Baroness Hallett's report calling for urgent reform. More than 24,000 claims have been submitted, but only just over 1% resulted in one-off payments of £120,000. The campaign group Vaccine Injured and Bereaved UK welcomed the recognition of the problem but demanded concrete commitments and timelines.
Aziz Karimov
